Related references
Note: Only part of the references are listed.Are the UK genetic testing criteria for dementia too exclusive?
Annita Christodoulidou et al.
JOURNAL OF NEUROLOGY (2021)
Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders
Aurelie de Rus Jacquet et al.
MOLECULAR PSYCHIATRY (2021)
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Tasuku Ishida et al.
SLAS DISCOVERY (2021)
A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models
Weijin Wang et al.
THERANOSTICS (2021)
Human pluripotent stem cell-derived models and drug screening in CNS precision medicine
M. Catarina Silva et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)
Back to the origins: Human brain organoids to investigate neurodegeneration
I. Faravelli et al.
BRAIN RESEARCH (2020)
Optical Control of Small Molecule-Induced Protein Degradation
Yuta Naro et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
PROTAC Technology: Opportunities and Challenges
Hongying Gao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Tau immunotherapies: Lessons learned, current status and future considerations
L. A. Sandusky-Beltran et al.
NEUROPHARMACOLOGY (2020)
Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons
M. Catarina Silva et al.
NATURE COMMUNICATIONS (2020)
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
Katherine A. Donovan et al.
CELL (2020)
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
Alina Mares et al.
COMMUNICATIONS BIOLOGY (2020)
A walk through tau therapeutic strategies
Santosh Jadhav et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
M. Catarina Silva et al.
ELIFE (2019)
Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs
Mari Nakamura et al.
STEM CELL REPORTS (2019)
Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML
Matthias Brand et al.
CELL CHEMICAL BIOLOGY (2019)
PROTACs: great opportunities for academia and industry
Xiuyun Sun et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling
N. Arul Murugan et al.
ACS CHEMICAL NEUROSCIENCE (2018)
An Overview on the Clinical Development of Tau-Based Therapeutics
Miguel Medina
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Plasticity in binding confers selectivity in ligand-induced protein degradation
Radoslaw P. Nowak et al.
NATURE CHEMICAL BIOLOGY (2018)
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
Lara N. Gechijian et al.
NATURE CHEMICAL BIOLOGY (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms
David T. Jones et al.
NEUROLOGY (2018)
Tau Kinetics in Neurons and the Human Central Nervous System (vol 97, pg 1284, 2018)
Chihiro Sato et al.
NEURON (2018)
Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation
Philipp M. Cromm et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP
Shan Jiang et al.
TRANSLATIONAL PSYCHIATRY (2018)
Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia
Jinsoo Seo et al.
JOURNAL OF NEUROSCIENCE (2017)
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment
Georg E. Winter et al.
MOLECULAR CELL (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
Frontotemporal Dementia
Nicholas T. Olney et al.
NEUROLOGIC CLINICS (2017)
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy
Sarah L. DeVos et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Tau passive immunization inhibits not only tau but also Aβ pathology
Chun-ling Dai et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
18F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study
Daniel R. Schonhaut et al.
ANNALS OF NEUROLOGY (2017)
Modeling tau pathology in human stem cell derived neurons
Selina Wray
BRAIN PATHOLOGY (2017)
Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway
Ian Collins et al.
BIOCHEMICAL JOURNAL (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
Ruben Smith et al.
BRAIN (2016)
Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice
Sumihiro Maeda et al.
EMBO REPORTS (2016)
The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity
Jochen Martin Decker et al.
EMBO REPORTS (2016)
Synthesis and quality control of [18F]T807 for tau PET imaging
Daniel P. Holt et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2016)
Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model
Ghulam Jeelani Pir et al.
MOLECULAR NEURODEGENERATION (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Kanak Raina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
Francesco Panza et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability
M. Catarina Silva et al.
STEM CELL REPORTS (2016)
An autoradiographic evaluation of AV-1451 Tau PET in dementia
Val J. Lowe et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations
Mariangela Iovino et al.
BRAIN (2015)
Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging
B. Ghetti et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Phenotypic heterogeneity of monogenic frontotemporal dementia
Alberto Benussi et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination
Meredith B. Metzger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide
Eric S. Fischer et al.
NATURE (2014)
Pharmacological targeting of the pseudokinase Her3
Ting Xie et al.
NATURE CHEMICAL BIOLOGY (2014)
Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs
Philip P. Chamberlain et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Neurodegenerative Disease Phenotypes in Carriers of MAPT p.A152T, A Risk Factor for Frontotemporal Dementia Spectrum Disorders and Alzheimer Disease
Suzee E. Lee et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2013)
[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Chun-Fang Xia et al.
ALZHEIMERS & DEMENTIA (2013)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimers diseases
Giovanni Coppola et al.
HUMAN MOLECULAR GENETICS (2012)
Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
Najla Kfoury et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles
Jing L. Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome
Steven D. Sheridan et al.
PLOS ONE (2011)
The heritability and genetics of frontotemporal lobar degeneration
J. D. Rohrer et al.
NEUROLOGY (2009)
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Anne E. Carpenter et al.
GENOME BIOLOGY (2006)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
Tau protein and neurodegeneration
M Goedert
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias
S Barghorn et al.
BIOCHEMISTRY (2000)
Share Paper
